Hepatocellular carcinoma in patients with chronic kidney disease

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 16

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

411

HTML

3560

Figures (1-2)

276

Tables (1-4)

250

Sum=4497

Publishing Process of This Article

Item

Count

Browse

1069

Download

1198

Sum=2267

Apr 28, 2013 (publication date) through Mar 2, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Apr 28, 2013; 19(16): 2466-2472
Published online Apr 28, 2013. doi: 10.3748/wjg.v19.i16.2466

Table 4 Cox regression analysis of mortality in patients with hepatocellular carcinoma and chronic kidney disease

Variable	Univariate analysis		Multivariate analysis
	Odds ratio (95%CI)	P value	Odds ratio (95%CI)	P value
Chronic kidney disease stage	2.237 (1.376-3.636)	0.001	1.988 (1.012-3.906)	0.046
Liver cirrhosis stage	4.566 (2.331-8.929)	0.000	3.571 (1.590-8.000)	0.002
Tumor stage	3.509 (1.789-6.849)	0.000	2.169 (0.997-4.717)	0.051
Albumin, each increase of 1 mg/dL	0.503 (0.399-0.633)	0.000	0.657 (0.491-0.878)	0.005
Prolonged prothrombin time, each increase of 1 s	1.062 (1.036-1.089)	0.000	0.977 (0.942-1.013)	0.215

Citation: Lee CH, Hsieh SY, Lin JL, Liu MS, Yen TH. Hepatocellular carcinoma in patients with chronic kidney disease. World J Gastroenterol 2013; 19(16): 2466-2472
URL: https://www.wjgnet.com/1007-9327/full/v19/i16/2466.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i16.2466